Back to Trades
Steinhart Richard I
Chief Financial OfficerCIK 0001293789
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Steinhart Richard I, Chief Financial Officer, accounts for 9 disclosed filings worth $7.4K, spread across 2 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $7.4K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jun 17 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| May 22 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Sell | $7.4K |
| May 14 | ATOS ATOSSA THERAPEUTICS, INC. | Steinhart Richard I | Insider | Grant | $0 |
| May 7 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Jan 5 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Award | $0 |
| Dec 15 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Sep 16 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Aug 5 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Award | $0 |
| Jul 22 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Grant | $0 |
9 filings